A

Aquestive Therapeutics Inc
NASDAQ:AQST

Watchlist Manager
Aquestive Therapeutics Inc
NASDAQ:AQST
Watchlist
Price: 3.52 USD -1.95% Market Closed
Market Cap: 321m USD
Have any thoughts about
Aquestive Therapeutics Inc?
Write Note

Balance Sheet

Balance Sheet Decomposition
Aquestive Therapeutics Inc

Current Assets 96.6m
Cash & Short-Term Investments 77.9m
Receivables 9.7m
Other Current Assets 9m
Non-Current Assets 13.4m
PP&E 9.2m
Other Non-Current Assets 4.2m
Current Liabilities 15.2m
Accounts Payable 7.6m
Accrued Liabilities 5.5m
Other Current Liabilities 2.1m
Non-Current Liabilities 140.2m
Long-Term Debt 31.3m
Other Non-Current Liabilities 109m

Balance Sheet
Aquestive Therapeutics Inc

Rotate your device to view
Balance Sheet
Currency: USD
Dec-2005 Dec-2006 Dec-2016 Dec-2017 Dec-2018 Dec-2019 Dec-2020 Dec-2021 Dec-2022 Dec-2023
Assets
Cash & Cash Equivalents
1
15
9
17
61
49
32
28
27
24
Cash Equivalents
1
15
9
17
61
49
32
28
27
24
Total Receivables
0
1
11
6
6
13
7
12
5
8
Accounts Receivables
0
1
11
6
6
13
7
12
5
8
Other Receivables
0
0
0
0
0
0
0
0
0
0
Inventory
1
0
3
4
5
3
2
4
6
7
Other Current Assets
0
0
0
1
2
3
3
3
2
2
Total Current Assets
2
17
23
28
74
68
45
47
40
41
PP&E Net
8
9
15
13
12
10
10
8
9
10
PP&E Gross
8
9
15
13
12
10
10
8
9
10
Accumulated Depreciation
1
2
28
32
35
38
41
40
42
43
Intangible Assets
2
2
0
0
0
0
0
0
1
1
Note Receivable
0
0
0
0
0
0
7
6
5
4
Other Long-Term Assets
1
0
1
1
0
0
1
1
1
1
Total Assets
12
N/A
27
+121%
39
+45%
43
+9%
87
+101%
78
-10%
63
-20%
62
-1%
57
-8%
57
+1%
Liabilities
Accounts Payable
1
1
7
10
20
12
7
8
10
9
Accrued Liabilities
0
1
3
4
7
5
9
10
8
7
Short-Term Debt
0
0
0
0
0
0
0
0
0
0
Current Portion of Long-Term Debt
0
0
0
0
5
0
3
2
19
0
Other Current Liabilities
0
0
1
2
1
1
2
2
3
2
Total Current Liabilities
2
2
11
15
33
19
21
22
40
18
Long-Term Debt
6
0
78
88
43
60
34
52
33
28
Other Liabilities
0
0
8
9
1
6
56
71
103
118
Total Liabilities
8
N/A
2
-75%
97
+4 931%
112
+16%
77
-31%
85
+10%
111
+32%
144
+29%
176
+22%
164
-7%
Equity
Common Stock
11
50
50
52
0
0
0
0
0
0
Retained Earnings
12
25
109
120
61
130
186
257
311
319
Additional Paid In Capital
5
0
1
0
71
124
138
175
193
213
Total Equity
5
N/A
25
+441%
57
N/A
69
-20%
10
N/A
6
N/A
49
-692%
82
-69%
119
-44%
106
+10%
Total Liabilities & Equity
12
N/A
27
+121%
39
+45%
43
+9%
87
+101%
78
-10%
63
-20%
62
-1%
57
-8%
57
+1%
Shares Outstanding
Common Shares Outstanding
15
15
25
25
25
34
35
41
55
69
Preferred Shares Outstanding
0
38
0
0
0
0
0
0
0
0

See Also

Discover More